Examinando por Autor "Zapata Rojas, Allan Paul"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Evaluación de la intervención farmacéutica en escenario de pandemia de COVID-19 en pacientes atendidos en la “Botica Chilca” distrito de Chilca, Cañete, Lima, Perú 2022
    (Universidad Privada Norbert Wiener, 2023-03-07) Zapata Rojas, Allan Paul; Villanueva Vílchez, Hugo Gilberto
    During the Covid-19 pandemic, the work of the Pharmaceutical Chemist focused on developing preventive, promotional, and assistance actions for the general population, especially for confirmed or suspected Covid-19 patients. Objective: To identify the relationship between pharmaceutical intervention and the Covid-19 pandemic scenario in patients attended at Botica Chilca, Chilca district, Cañete, Lima, Peru, 2022. Methods: The research method was hypothetical-deductive, quantitative, basic, with a non-experimental, observational, prospective, and correlational design. The sample consisted of 110 patients. Results: Among the 110 patients, 53.6% were women, 49.1% married, and 43.6% aged between 20-40 years. Additionally, 53.6% had received the second dose of the Covid-19 vaccine, and 34.5% the third dose. Regarding medication consumption, 64.5% used prescribed medication, 34.5% used medicinal plants; 41.8% underwent diagnostic testing, and 40.9% were confirmed to have Covid-19. Common symptoms included sore throat (71.8%), headache (61.8%), general discomfort and pain (59.1%), fatigue (69.1%), fever (52.7%), and dry cough (61.8%). Moreover, 85.5% had oxygen saturation below 94; 27.3% were hypertensive, and 14.5% asthmatic. Medication use included paracetamol (53.6%), dexamethasone (33.6%), and cephalosporins (24.5%), while 45.5% did not use antibiotics. Furthermore, 79.1% reported no adverse effects, 64.5% adhered to therapy, 70% received pharmaceutical counseling on the disease and medication, and 76.4% experienced symptom improvement. Conclusion: A significant relationship was identified between pharmaceutical intervention and the Covid-19 pandemic scenario in patients attended at Botica Chilca.